TYROSINE KINASE MUTATION

This adverse event was reported 25 times

These drugs are most commonly taken by patients reporting TYROSINE KINASE MUTATION:

# Drug Count
0 IBRUTINIB 6
1 VENETOCLAX 6
2 HYDROXYUREA 5
3 NILOTINIB 5
4 PONATINIB HYDROCHLORIDE 5
5 RITUXIMAB 5
6 BOSUTINIB 4
7 CHLORAMBUCIL 4
8 CYCLOPHOSPHAMIDE 4
9 CYCLOPHOSPHAMIDE FOR INJECTION 4
See all common drugs associated with TYROSINE KINASE MUTATION

TYROSINE KINASE MUTATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CHLORAMBUCIL 4 0.0010
1 PONATINIB HYDROCHLORIDE 5 0.0010
2 AFATINIB 3 0.0005
3 BOSUTINIB 4 0.0004
4 DASATINIB 4 0.0004
5 GEFITINIB 3 0.0003
6 HYDROXYUREA 5 0.0002
7 NILOTINIB 5 0.0002
8 FLUDARABINE PHOSPHATE 4 0.0001
9 VENETOCLAX 6 0.0001
See all drugs enriched for association with TYROSINE KINASE MUTATION

TYROSINE KINASE MUTATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 BCL-2 Inhibitor [EPC] 6 0.0001
1 Kinase Inhibitor [EPC] 17 0.0000
2 Alkylating Drug [EPC] 4 0.0000
3 CD20-directed Cytolytic Antibody [EPC] 5 0.0000
4 Janus Kinase Inhibitor [EPC] 1 0.0000
5 Corticosteroid [EPC] 5 0.0000
See all drug classes enriched for association with TYROSINE KINASE MUTATION